Sanofi India Ltd. - Research Center
500674 SANOFI Group (A) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Jun ' 23 | Dec ' 22 | Jun ' 22 | Dec ' 21 | Jun ' 21 | |
|---|---|---|---|---|---|
| Sales | 1,442.60 | 1,363.80 | 1,406.30 | 1,442.40 | 1,514.20 |
| Operating profit | 408.10 | 348.80 | 355.60 | 326.00 | 436.50 |
| Interest | 1.00 | 0.90 | 0.80 | 0.90 | 0.90 |
| Gross profit | 448.60 | 379.30 | 394.90 | 356.10 | 479.00 |
| EPS (Rs) | 136.22 | 113.83 | 156.00 | 269.65 | 140.96 |
Half yearly
results in details
| Jun ' 23 | Dec ' 22 | Jun ' 22 | Dec ' 21 | Jun ' 21 | |
|---|---|---|---|---|---|
| Other income | 41.50 | 31.40 | 40.10 | 31.00 | 43.40 |
| Stock adjustment | -78.20 | 61.60 | -72.70 | -0.40 | 43.50 |
| Raw material | 299.90 | 244.40 | 305.30 | 274.40 | 280.70 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 185.50 | 200.90 | 205.00 | 215.60 | 218.30 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 627.30 | 508.10 | 613.10 | 626.80 | 535.20 |
| Provisions made | - | - | - | - | - |
| Depreciation | 19.50 | 20.40 | 21.50 | 25.20 | 41.50 |
| Taxation | 133.60 | 111.00 | 132.70 | 199.90 | 113.30 |
| Net profit / loss | 313.30 | 261.80 | 358.80 | 620.20 | 324.20 |
| Extra ordinary item | 17.80 | 13.90 | 118.10 | 489.20 | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 28.29 | 25.58 | 25.29 | 22.60 | 28.83 |
| GPM (%) | 30.23 | 27.19 | 27.30 | 24.17 | 30.75 |
| NPM (%) | 21.11 | 18.76 | 24.81 | 42.09 | 20.81 |
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis